FDX
33
-11
WDC
40
3
WMB
60
2
OXY
34
-8
CLX
62
-3
BIIB
39
2
DVN
24
2
STX
38
4
SNA
56
-2
ICE
55
2
NWSA
71
2
WBA
38
-3
SYF
76
-2
ABBV
46
4
PGR
49
4
M
46
6
UNH
44
2
JWN
60
-9
LB
19
3
EXR
31
-11
FDX
33
-11
WDC
40
3
WMB
60
2
OXY
34
-8
CLX
62
-3
BIIB
39
2
DVN
24
2
STX
38
4
SNA
56
-2
ICE
55
2
NWSA
71
2
WBA
38
-3
SYF
76
-2
ABBV
46
4
PGR
49
4
M
46
6
UNH
44
2
JWN
60
-9
LB
19
3
EXR
31
-11
Financhill
Back

GlycoMimetics 10K Form

Sell
13

GLYC
GlycoMimetics

Last Price:
$0.24
Seasonality Move:
-6.72%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-09 10Q GLYC/GlycoMimetics Quarterly
2023-11-03 10Q GLYC/GlycoMimetics Quarterly
2023-08-02 10Q GLYC/GlycoMimetics Quarterly
2023-05-03 10Q GLYC/GlycoMimetics Quarterly
2022-11-09 10Q GLYC/GlycoMimetics Quarterly
2022-08-03 10Q GLYC/GlycoMimetics Quarterly

Receive GLYC News And Ratings

See the #1 stock for the next 7 days that we like better than GLYC

GLYC Financial Statistics

Sales & Book Value

Annual Sales: $10K
Cash Flow: $-8M
Price / Cash Flow: 0
Annual Sales: $0.18
Price / Book: 1.23

Profitability

EPS (TTM): -0.62000
Net Income (TTM): $-39.7M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

GlycoMimetics Earnings Forecast

Key GlycoMimetics Financial Ratios

  • The Gross Profit Margin over the past 4 years for GLYC is 0.00%.
  • The Selling, General & Administrative Expenses for GLYC have been equal to 192,130.00% of Gross Profit Margin.
  • The Research & Development expenses have been 200,716.60% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of GLYC is -368,994.20% of Total Revenues.
  • Per Share Earnings over the last 13 years have been positive in 6 years.

GlycoMimetics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: GLYC
CUSIP: 38000Q
Website: glycomimetics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

GLYC Technical Analysis vs Fundamental Analysis

Sell
13
GlycoMimetics (GLYC) is a Sell

Is GlycoMimetics a Buy or a Sell?

  • GlycoMimetics stock is rated a Sell
    The current GlycoMimetics [GLYC] share price is $0.22. The Score for GLYC is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.